Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 2;13(10):936.
doi: 10.3390/antibiotics13100936.

The Diverse Activities and Mechanisms of the Acylphloroglucinol Antibiotic Rhodomyrtone: Antibacterial Activity and Beyond

Affiliations
Review

The Diverse Activities and Mechanisms of the Acylphloroglucinol Antibiotic Rhodomyrtone: Antibacterial Activity and Beyond

Rupa Rani et al. Antibiotics (Basel). .

Abstract

Background/Objectives: The rose myrtle Rhodomyrtus tomentosa is a medicinal plant used in traditional Asian medicine. The active compound in R. tomentosa leaf extracts is rhodomyrtone, a chiral acylphloroglucinol. Rhodomyrtone exhibits an impressive breadth of activities, including antibacterial, antiviral, antiplasmodial, immunomodulatory, and anticancer properties. Its antibacterial properties have been extensively studied. Methods: We performed a comprehensive literature review on rhodomyrtone and summarized the current knowledge about this promising acylphloroglucinol antibiotic and its diverse functions in this review. Results: Rhodomyrtone shows nano to micromolar activities against a broad range of Gram-positive pathogens, including multidrug-resistant clinical isolates, and possesses a unique mechanism of action. It increases membrane fluidity and creates hyperfluid domains that attract membrane proteins prior to forming large membrane vesicles, effectively acting as a membrane protein trap. This mechanism affects a multitude of cellular processes, including cell division and cell wall synthesis. Additionally, rhodomyrtone reduces the expression of inflammatory cytokines, such as TNF-α, IL-17A, IL1β, and IL8. Generally showing low toxicity against mammalian cells, rhodomyrtone does inhibit the proliferation of cancer cell lines, such as epidermal carcinoma cells. The primary mechanism behind this activity appears to be the downregulation of adhesion kinases and growth factors. Furthermore, rhodomyrtone has shown antioxidant activity and displays cognitive effects, such as decreasing depressive symptoms in mice. Conclusions: Rhodomyrtone shows great promise as therapeutic agent, mostly for antibacterial but also for diverse other applications. Yet, bottlenecks such as resistance development and a better understanding of mammalian cell toxictiy demand careful assessment.

Keywords: Rhodomyrtus tomentosa; acylphloroglucinol; antimicrobial activity; mode of action; natural product; plant-derived antimicrobials; rhodomyrtone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Structures of acylphloroglucinols. (a) General structure of acylphloroglucinol compounds. (b) Structure of (R)-rhodomyrtone. (c) Structure of (S)-rhodomyrtone.
Figure 2
Figure 2
Structures of rhodomyrtone (a) and C7-modified rhodomyrtone derivatives with improved activity against S. aureus.
Figure 3
Figure 3
Effects of rhodomyrtone on bacterial cells. (a) Schematic overview of cellular effects. (b) Rhodomyrtone-induced vesicles visualized with structured illumination microscopy. (c) Vesicles visualized with transmission electron microscopy. Membranes were stained with Mitotracker green. (d) Trapping of the integral membrane protein MraY in rhodomyrtone-induced vesicles. Membranes were stained with FM5-95. Panels (bd) show Bacillus subtilis cells and were reproduced from [25].
Figure 4
Figure 4
Structures of non-pore-forming membrane-active antimicrobials with well-characterized mechanisms. (a) cWFW (cycloRRRWFW), (b) MP196 (RWRWRW-NH2), (c) daptomycin (N-Decanoyl-Trp–D-Asn–Asp–Thr–Gly–Orn–Asp–D-Ala–Asp–Gly–D-Ser–3-Me-Glu–Kyn), and (d) gramicidin S (cyclo(-Val-Orn-Leu-D-Phe-Pro-)2).
Figure 5
Figure 5
Mechanism of action of rhodomyrtone and other membrane-active compounds on bacterial cell membranes. Figure partially adapted from [78].
Figure 6
Figure 6
Resistance mechanism of S. aureus against rhodomyrtone according to results by Nguyen et al. and Huang et al. [85,87]. Green arrows indicate upregulation.
Figure 7
Figure 7
Effects of rhodomyrtone on mammalian cells. (1) Immunomodulatory, (2) anticancer, (3) antioxidant, and (4) cognitive effects of rhodomyrtone. Red arrows indicate down-regulation.

Similar articles

References

    1. AlSheikh H.M.A., Sultan I., Kumar V., Rather I.A., Al-Sheikh H., Tasleem Jan A., Haq Q.M.R. Plant-Based Phytochemicals as Possible Alternative to Antibiotics in Combating Bacterial Drug Resistance. Antibiotics. 2020;9:480. doi: 10.3390/antibiotics9080480. - DOI - PMC - PubMed
    1. Arip M., Selvaraja M., Rajagopal M., Tan L.F., Leong M.Y., Tan P.L., Yap V.L., Chinnapan S., Tat N.C., Abdullah M., et al. Review on Plant-Based Management in Combating Antimicrobial Resistance—Mechanistic Perspective. Front. Pharmacol. 2022;13:879495. doi: 10.3389/fphar.2022.879495. - DOI - PMC - PubMed
    1. World Health Organization . The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on the Selection and Use of Essential Medic. World Health Organization; Geneva, Switzerland: 2023. Web Annex A: World Health Organization Model List of Essential Medicines—23rd List, 2023.
    1. World Health Organization . WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. World Health Organization; Geneva, Switzerland: 2024.
    1. World Health Organization . WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. World Health Organization; Geneva, Switzerland: 2022.

LinkOut - more resources